American International Group, Inc. Castle Biosciences Inc Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Castle Biosciences Inc stock. As of the latest transaction made, American International Group, Inc. holds 12,244 shares of CSTL stock, worth $266,551. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,244

Previous 12,349 0.85%

Holding current value

$266,551

Previous $266,000 1.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$18.06 - $25.3 $1,896 - $2,656	-105 Reduced 0.85%	12,244 $271,000
Q4 2023 Feb 13, 2024	SELL	$12.19 - $22.43 $609 - $1,121	-50 Reduced 0.4%	12,349 $266,000
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $5,856 - $8,952	441 Added 3.69%	12,399 $209,000
Q2 2023 Aug 04, 2023	BUY	$11.66 - $26.0 $1,352 - $3,016	116 Added 0.98%	11,958 $164,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $4,575 - $6,695	235 Added 2.02%	11,842 $269,000

Q4 2022 Feb 10, 2023	SELL	$18.08 - $30.0 $759 - $1,260	-42 Reduced 0.36%	11,607 $273,000
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $11,682 - $17,812	519 Added 4.66%	11,649 $304,000
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $8,832 - $25,386	552 Added 5.22%	11,130 $244,000
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $24,711 - $35,000	-745 Reduced 6.58%	10,578 $475,000
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $13,241 - $22,909	-339 Reduced 2.91%	11,323 $485,000
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $16,595 - $21,417	-276 Reduced 2.31%	11,662 $776,000
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $172,691 - $264,814	3,449 Added 40.63%	11,938 $875,000
Q1 2021 May 07, 2021	BUY	$58.92 - $97.33 $93,800 - $154,949	1,592 Added 23.08%	8,489 $581,000
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $5,101 - $8,546	-117 Reduced 1.67%	6,897 $463,000
Q3 2020 Nov 04, 2020	BUY	$38.47 - $52.03 $28,660 - $38,762	745 Added 11.88%	7,014 $361,000
Q2 2020 Aug 12, 2020	BUY	$27.28 - $43.01 $17,977 - $28,343	659 Added 11.75%	6,269 $236,000
Q1 2020 May 04, 2020	BUY	$23.08 - $35.53 $74,733 - $115,046	3,238 Added 136.51%	5,610 $167,000
Q4 2019 Feb 05, 2020	BUY	$15.74 - $35.04 $629 - $1,401	40 Added 1.72%	2,372 $82,000
Q3 2019 Nov 08, 2019	BUY	$18.09 - $27.92 $42,185 - $65,109	2,332 New	2,332 $42,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Castle Biosciences Inc Transaction History